Intensive therapy not superior for diabetes complications

May 20, 2014
Intensive therapy not superior for diabetes complications

(HealthDay)—Compared with routine care, early multifactorial therapy did not result in superior microvascular outcomes at five years in individuals with screening-detected diabetes, according to research published online May 1 in Diabetes Care.

Annelli Sandbaek, M.D., Ph.D., of the University of Aarhus in Denmark, and colleagues followed up 2,861 of 3,057 individuals with type 2 diabetes detected by screening who had been randomly assigned to intensive treatment or routine care. The authors sought to assess the effect of treatment type on .

The researchers found, at five years, in the intensive treatment group and the routine care group, respectively, any kind of albuminuria in 22.7 and 24.4 percent of individuals (odds ratio [OR], 0.87; 95 percent confidence interval [CI], 0.72 to 1.07), retinopathy in 10.2 and 12.1 percent (OR, 0.84; 95 percent CI, 0.64 to 1.10), and neuropathy in 4.9 and 5.9 percent (OR, 0.95; 95 percent CI, 0.68 to 1.34). Between baseline and follow-up, estimated increased in both groups (4.31 and 6.44 mL/min, respectively).

"Compared with routine care, an intervention to promote target-driven, intensive management of patients with detected by screening was not associated with significant reductions in the frequency of microvascular events at five years," the authors write.

Several authors disclosed financial ties to pharmaceutical companies, including those which contributed funding to the study.

Explore further: Metformin use doesn't cut incidence of bladder cancer

More information: Abstract
Full Text (subscription or payment may be required)

Related Stories

Metformin use doesn't cut incidence of bladder cancer

February 11, 2014

(HealthDay)—For patients with type 2 diabetes, metformin use is not associated with a significantly reduced risk of bladder cancer, according to a study published online Feb. 4 in Diabetes Care.

Interarm BP difference may up cardiac risk in diabetes

April 3, 2014

(HealthDay)—Interarm differences in systolic blood pressure (BP) in patients with diabetes may be associated with an increased risk of cardiovascular morbidity and mortality, according to research published online on March ...

Serum marker predicts cardiovascular events in diabetes

April 25, 2014

(HealthDay)—Elevated levels of polyclonal serum immunoglobulin combined free light chains (cFLCs) may indicate adverse cardiovascular disease (CVD) outcomes in patients with type 2 diabetes, according to research published ...

Many at high cardiovascular risk still not on statins

May 13, 2014

(HealthDay)—Many individuals at high risk for cardiovascular events, such as those with coronary artery disease, diabetes, or both, are not receiving statins, according to research published in the May/June issue of the ...

Recommended for you

Diets avoiding dry-cooked foods can protect against diabetes

August 24, 2016

Simple changes in how we cook could go a long way towards preventing diabetes, say researchers at the Icahn School of Medicine at Mount Sinai. A new randomized controlled trial, published online July 29 in the journal Diabetologia, ...

New study reveals a novel protein linked to type 2 diabetes

August 16, 2016

Findings from Boston University School of Medicine (BUSM), which appear in eLife, provide a possible explanation as to why most people who are obese develop insulin resistance and type 2 diabetes. A minority of obese individuals, ...

Bacteria may cause type 2 diabetes

June 1, 2015

Bacteria and viruses have an obvious role in causing infectious diseases, but microbes have also been identified as the surprising cause of other illnesses, including cervical cancer (Human papilloma virus) and stomach ulcers ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.